How to Talk to Your Cancer Patients About Their COVID-19 Risk

Dr. Mikkael Sekeres in his latest New York Times column

Patients with cancer, and especially those receiving treatment, are approaching their physicians with questions about their risk of contracting COVID-19. Mikkael Sekeres, MD, MS, Director of Cleveland Clinic Cancer Center’s Leukemia Program, offers an expert’s perspective on the existing research in his latest New York Times column. His answer to the question of whether cancer and chemotherapy increase the risk of death from COVID-19 provides a comprehensive look at existing research in patient-friendly language that can be a useful tool in communicating with your patients.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

Read the column here.

Follow Dr. Sekeres on Twitter @MikkaelSekeres.